Multiplying messages LRRK beneath parkinson disease

William T. Dauer; Ming Guo

doi:10.1016/j.cell.2014.03.043

Multiplying messages LRRK beneath parkinson disease

Research output: Contribution to journal › Short survey › peer-review

Abstract

Parkinson Disease (PD) is a progressive neurodegenerative disorder with limited therapeutic options. In this issue of Cell, Martin et al. link PD protein leucine-rich repeat kinase 2 (LRRK2) to abnormalities of translational control, a pathogenic mechanism implicated in an increasing number of CNS neurodegenerative diseases, as well as in normal aging.

Original language	English (US)
Pages (from-to)	291-293
Number of pages	3
Journal	Cell
Volume	157
Issue number	2
DOIs	https://doi.org/10.1016/j.cell.2014.03.043
State	Published - Apr 10 2014
Externally published	Yes

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1016/j.cell.2014.03.043

Cite this

@article{949a37f08a2c4ea5b90d4ad4e304b1fc,

title = "Multiplying messages LRRK beneath parkinson disease",

abstract = "Parkinson Disease (PD) is a progressive neurodegenerative disorder with limited therapeutic options. In this issue of Cell, Martin et al. link PD protein leucine-rich repeat kinase 2 (LRRK2) to abnormalities of translational control, a pathogenic mechanism implicated in an increasing number of CNS neurodegenerative diseases, as well as in normal aging.",

author = "Dauer, {William T.} and Ming Guo",

note = "Funding Information: We regret being unable to cite all relevant work because of space constrains. We thank Peter Todd for insightful discussions. Supported by the National Institute of Health (NIH) to W.T.D., and NIH, Ellison Medical Foundation and American Parkinson Disease Association to M.G.",

year = "2014",

month = apr,

day = "10",

doi = "10.1016/j.cell.2014.03.043",

language = "English (US)",

volume = "157",

pages = "291--293",

journal = "Cell",

issn = "0092-8674",

publisher = "Cell Press",

number = "2",

}

TY - JOUR

T1 - Multiplying messages LRRK beneath parkinson disease

AU - Dauer, William T.

AU - Guo, Ming

N1 - Funding Information: We regret being unable to cite all relevant work because of space constrains. We thank Peter Todd for insightful discussions. Supported by the National Institute of Health (NIH) to W.T.D., and NIH, Ellison Medical Foundation and American Parkinson Disease Association to M.G.

PY - 2014/4/10

Y1 - 2014/4/10

N2 - Parkinson Disease (PD) is a progressive neurodegenerative disorder with limited therapeutic options. In this issue of Cell, Martin et al. link PD protein leucine-rich repeat kinase 2 (LRRK2) to abnormalities of translational control, a pathogenic mechanism implicated in an increasing number of CNS neurodegenerative diseases, as well as in normal aging.

AB - Parkinson Disease (PD) is a progressive neurodegenerative disorder with limited therapeutic options. In this issue of Cell, Martin et al. link PD protein leucine-rich repeat kinase 2 (LRRK2) to abnormalities of translational control, a pathogenic mechanism implicated in an increasing number of CNS neurodegenerative diseases, as well as in normal aging.

UR - http://www.scopus.com/inward/record.url?scp=84898607276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898607276&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2014.03.043

DO - 10.1016/j.cell.2014.03.043

M3 - Short survey

C2 - 24725399

AN - SCOPUS:84898607276

SN - 0092-8674

VL - 157

SP - 291

EP - 293

JO - Cell

JF - Cell

IS - 2

ER -

Multiplying messages LRRK beneath parkinson disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this